Press "Enter" to skip to content

New patent expiration for Novartis drug STARLIX


Annual Drug Patent Expirations for STARLIX
Annual Drug Patent Expirations for STARLIX

Starlix is a drug marketed by Novartis
and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has sixty-three patent family members in thirty-five countries.

The generic ingredient in STARLIX is nateglinide. One supplier is listed for this compound. Additional details are available on the nateglinide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!